Sofinnova Crossover I

13D and 13G Filings

13D/G filings: 13D on 1 security, 13G on 1 security
CIK: 0001845105
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Abivax S.A. 13D/A Amendment 6 ABVX · 00370M103	ABVX	00370M103	4.3%	3,535,843	13D/A Amendment 6	7/6/2026 Event 7/2/2026
Sofinnova Crossover I SLP			4.3%	3,535,843
Sofinnova Partners SAS			4.3%	3,535,843
Antoine Papiernik			4.3%	3,535,843
Cedric Moreau			4.3%	3,535,843
Kinam Hong			4.3%	3,535,843
Joseph Anderson			4.3%	3,535,843
Jacques Theurillat			4.3%	3,535,843
Abivax S.A. 13D/A Amendment 5 ABVX · 00370M103	ABVX	00370M103	6.7%	5,499,478	13D/A Amendment 5	5/11/2026 Event 5/7/2026
Sofinnova Crossover I SLP			6.7%	5,499,478
Sofinnova Partners SAS			6.7%	5,499,478
Antoine Papiernik			6.7%	5,499,478
Cedric Moreau			6.7%	5,499,478
Kinam Hong			6.7%	5,499,478
Joseph Anderson			6.7%	5,499,478
Jacques Theurillat			6.7%	5,499,478
Inventiva, S.A. 13G/A Amendment 5 IVA · 46124U107	IVA	46124U107	8.6%	19,086,050	13G/A Amendment 5	2/17/2026 Event 12/31/2025
Sofinnova Crossover I SLP			5.6%	12,332,804
Sofinnova Crossover II SLP			3.1%	6,753,246
Sofinnova Partners SAS, a French corporation			8.6%	19,086,050
Antoine Papiernik			8.6%	19,086,050
Cedric Moreau			8.6%	19,086,050
Kinam Hong			8.6%	19,086,050
Joseph Anderson			8.6%	19,086,050
Jacques Theurillat			5.6%	12,332,804
Abivax S.A. 13D/A Amendment 4 ABVX · 00370M103	ABVX	00370M103	7.7%	6,399,478	13D/A Amendment 4	1/14/2026 Event 1/12/2026
Sofinnova Crossover I SLP			7.7%	6,399,478
Sofinnova Partners SAS			7.7%	6,399,478
Antoine Papiernik			7.7%	6,399,478
Cedric Moreau			7.7%	6,399,478
Kinam Hong			7.7%	6,399,478
Joseph Anderson			7.7%	6,399,478
Jacques Theurillat			7.7%	6,399,478
Abivax SA 13D/A Amendment 3 ABVX · 00370M103	ABVX	00370M103	9.4%	8,399,478	13D/A Amendment 3	10/30/2025 Event 10/28/2025
Sofinnova Crossover I SLP			9.4%	8,399,478
Sofinnova Partners SAS			9.4%	8,399,478
Antoine Papiernik			9.4%	8,399,478
Cedric Moreau			9.4%	8,399,478
Kinam Hong			9.4%	8,399,478
Joseph Anderson			9.4%	8,399,478
Jacques Theurillat			9.4%	8,399,478
Abivax SA 13D/A Amendment 2 ABVX · 00370M103	ABVX	00370M103	11.4%	9,599,478	13D/A Amendment 2	7/31/2025 Event 7/23/2025
Sofinnova Crossover I SLP			11.4%	9,599,478
Sofinnova Partners SAS			11.4%	9,599,478
Antoine Papiernik			11.4%	9,599,478
Cedric Moreau			11.4%	9,599,478
Kinam Hong			11.4%	9,599,478
Joseph Anderson			11.4%	9,599,478
Jacques Theurillat			11.4%	9,599,478
Inventiva, S.A. 13G/A Amendment 4 IVA · 46124U107	IVA	46124U107	7.2%	7,792,307	13G/A Amendment 4	2/14/2025 Event 12/31/2024
Sofinnova Crossover I SLP			7.2%	7,792,307
Sofinnova Partners SAS, a French corporation			7.2%	7,792,307
Antoine Papiernik			7.2%	7,792,307
Cedric Moreau			7.2%	7,792,307
Kinam Hong			7.2%	7,792,307
Joseph Anderson			7.2%	7,792,307
Jacques Theurillat			7.2%	7,792,307
Abivax SA 13D/A Amendment 1 ABVX · 00370M103	ABVX	00370M103	11.0%	7,794,478	13D/A Amendment 1	2/14/2025 Event 2/14/2025
Sofinnova Crossover I SLP			11.0%	7,794,478
Sofinnova Partners SAS			11.0%	7,794,478
Antoine Papiernik			11.0%	7,794,478
Cedric Moreau			11.0%	7,794,478
Kinam Hong			11.0%	7,794,478
Joseph Anderson			11.0%	7,794,478
Jacques Theurillat			11.0%	7,794,478

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.